Stock Watch: Positive Trial Announcements Need A Pinch Of Salt
Only After The FDA Has Had Its Say Can Celebrations Begin
Executive Summary
The announcement of a positive clinical trial and an intention to proceed to a regulatory submission are causes for a company’s investors to rejoice. Sometimes that can be premature.